oxygen used as prescribed (usually more than 20 hours per day) is
the only non-surgical treatment which has been shown to prolong life
in emphysema patients.
volume reduction surgery (LVRS) can improve the quality of life for
certain carefully selected patients. It can be done by different methods,
some of which are minimally invasive.
after Lung Volume Reduction Surgery (LVRS) may not last greater than
two to three years, however, during this time, select patients may
experience significant clinical benefits, and allow safe bridging
toward lung transplantation, if necessary.
at Cedars-Sinai Medical Center announced the start of the EASE (Exhale
Airway Stents for Emphysema) Trial, an international, multi-center
clinical trial to explore an investigational treatment that may offer
a new, minimally-invasive option for those suffering with advanced
focuses on an experimental procedure called airway bypass designed
to create pathways in the lung for trapped air to escape with the
goal of relieving shortness of breath and other emphysema.
published by the European Respiratory Journal suggests that tretinoin
(an anti-acne drug commercially available as Accutane) derived from
vitamin A can reverse the effects of emphysema in mice by returning
elasticity (and regenerating
lung tissue through gene mediation) to the alveoli.
research performed at Georgetown University has provided some hope
for a cure - a treatment that will regenerate lung tissue. In their
work, Drs. Gloria and Donald Massaro tested a derivative of Vitamin
A, called all-trans-retinoic acid (ATRA), on rats suffering from an
experimental form of emphysema.
with ATRA helped regenerate their lungs and restore their damaged
lungs and lung function.
of n-acetyl cysteine (NAC) supplements three times a day might help
with the symptoms associated with emphysema disease.
cysteine (NAC) is an amino acid which can help to increase the levels
of the powerful antioxidant glutathione in the respiratory track.
cysteine (NAC) is good at reducing mucus production in the respiratory
track and its antioxidant properties can help to protect against lung
tissue damage associated emphysema disease.
members of Efforts (EMPHYSEMA FOUNDATION FOR OUR RIGHT TO SURVIVE
) with COPD had umbilical cord stem cell transplants on April 5th
of this year and have noticed some improvements already. The treatment
injected own cells via IV and umbilical cord stem cells through an
used drugs in emphysema clinical trials right now are:
Retinoic acid. The oxidized form of Vitamin A
Alpha-1 Proteinase Inhibitor
the past century, a variety of surgical procedures have been proposed
to improve the symptoms and quality of life in patients with severe
emphysema, it can be expected that new drugs will be developed in
the future in an attempt. to specifically treat airway or parenchymal
new government study shows that patients with severe emphysema who
undergo bilateral lung volume reduction surgery (LVRS) on average
do not face an increased risk of death, and are more likely to function
better compared to those who receive only non-surgical treatment.
also identified specific criteria to determine which patients will
benefit from the procedure. The five-year randomized study, known
as the National Emphysema Treatment Trial (NETT), represents an unprecedented
collaboration between the National Institutes of Health (NIH) and
Medicare, and was the combined effort of 17 clinical research sites.